Deborah Cardinali | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study	HAEMATOLOGICA	2024
Measurable Residual Disease Monitoring for Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ALL) in the Setting of the GIMEMA ALL2820 Trial	BLOOD	2024
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures	MOLECULAR ONCOLOGY	2023
A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia	HEMATOLOGICAL ONCOLOGY	2023
DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA	European Hematology Association (EHA) 2023 Open Library	2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase	LEUKEMIA & LYMPHOMA	2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia	CANCERS	2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia	CANCERS	2023
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings	LEUKEMIA & LYMPHOMA	2022
Digital Droplet PCR for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia Using IG/TR Genes and BCR/ABL1 as Markers. Preliminary Results of a Comparative Analysis	BloodBLOOD	2022